Altimmune: Updated Data Supports Pemvidutide's 'Market Disruptor' Prospects
Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...
Weight loss surgery cuts kidney failure risk by 44% in diabetics: Study
The study published in the Annals of Surgery found that bariatric surgery was linked to a 60% lower risk of kidney disease ...
The Brighterside of News on MSN9h
Weight-loss drug Semaglutide could significantly reduce the risk of heart attacks
A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...
Does Ozempic work for long-term weight loss? New study says yes
Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...
Does ‘nature’s Ozempic’ really work? Trendy GLP-1 supplements are designed to supercharge weight loss for a fraction of the price
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...